Cannabis Therapy Corp. (CTCO) 0.1820 $CTCO 99 Marijuana

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cannabis Therapy Corp. (CTCO) 0.1820 $CTCO

99 Marijuana Stocks For Your Do Not 'Buy And Hold' List
Anthony Cataldo - at Seeking Alpha - Mon Feb 02, 6:25AM CST

GWPH: 105.64 (+0.79), FULL: 3.13 (-0.02), CARA: 20.89 (+0.45), ICN: 20.50 (unch)

Marijuana Firms - Exploring N=99, Ranked By Market Capitalization
Anthony Cataldo - at Seeking Alpha - Mon Feb 02, 3:34AM CST

GWPH: 105.64 (+0.79), FULL: 3.13 (-0.02), CARA: 20.89 (+0.45)

12 Marijuana Stocks For Your Do Not 'Buy And Hold' List - Part VIII
Anthony Cataldo - at Seeking Alpha - Wed Jan 28, 6:48AM CST

GWPH: 105.64 (+0.79), DE: 79.25 (-0.82), FULL: 3.13 (-0.02), CARA: 20.89 (+0.45)

CannabisFN: What to Watch in the Week Ahead
ACCESSWIRE - Tue Jan 20, 1:00PM CST
WHITEFISH, MT / ACCESSWIRE / January 20, 2015 / The cannabis industry began the new year on a high note, with the Marijuana Index(TM) rebounding off of its 52-week lows established on December 31, 2014. With Peter Thiel's big decision to invest in the pot industry and favorable new legislation being introduced, investors' appetite for marijuana stocks could be on the rise in 2015 after a rough end to 2014. The venture market for weed stocks has also been on the rise, which suggests that some big-name initial public offerings could be on the way as the industry matures.
MGW.VN: 0.035 (-0.005)

This Is Where The Investment Opportunity Is Right Now In Cannabis
Small Cap Reporter - at Seeking Alpha - Tue Jan 20, 11:25AM CST

INSY: 36.20 (+0.23), GWPH: 105.64 (+0.79)

Peak Pharmaceuticals Is Pleased to Announce Strong Order Volume for Its Canna-Pet Products
Marketwired - Thu Jan 15, 7:55AM CST
Peak Pharmaceuticals, Inc. (OTCQB: CTCO) ("Peak Pharma" or the "Company", a growth stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, hemp-based, medicinal therapies and supplements (Nutraceuticals) for both humans and animals is pleased to advise of recent corporate achievements.

PEAK Pharmaceuticals Lays Out Plan to Drive Value in 2015
ACCESSWIRE - Wed Jan 14, 8:45AM CST
WHITEFISH, MT / ACCESSWIRE / January 14, 2015 / PEAK Pharmaceuticals Inc. (OTC: CTCO) has made tremendous strides over the past year targeting the biotechnology side of the cannabis industry. After signing a worldwide license agreement with Canna-Pet LLC and a cultivation agreement with a Colorado-based hemp farm, the company changed its name from Cannabis Therapy Corp. to PEAK Pharmaceuticals, Inc. to better reflect its focus on development and sales of pharmaceutical grade, hemp-based medicinal products for humans and pets.
GWPH: 105.64 (+0.79), WOOF: 56.07 (+0.76), PETM: 82.98 (+0.03)

Peak Pharmaceuticals, Inc. Announces Name Change From Cannabis Therapy Corp.
Marketwired - Tue Jan 13, 7:58AM CST
Peak Pharmaceuticals, Inc. (OTCQB: CTCO), formerly Cannabis Therapy Corp. (the "Company", a growth stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, hemp-based medicinal therapies and supplements (Nutraceuticals), wishes to advise that on December 23, 2014, Cannabis Therapy Corp., a Nevada corporation, entered into an Agreement and Plan of Merger pursuant to which the shareholders of the Company became shareholders of the surviving company named Peak Pharmaceuticals, Inc., a Nevada corporation.

Cannabis Therapy Corp. to Present at SeeThruEquity MicroCap Investor Forum November 12th in NYC
Marketwired - Fri Nov 07, 8:01AM CST
Cannabis Therapy Corp. (OTCQB: CTCO) (the "Company", a development stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, cannabinoid-based medicinal therapies and supplements (Nutraceuticals), today announced that Company CEO Dr. Soren Mogelsvang PhD and CFO Mr. Arnold Tinter will be presenting at SeeThruEquity's upcoming fall 2014 Microcap Investor Conference, being held at New York City's Convene Midtown East on November 12, 2014 at 10:00 A.M. Eastern.

Cannabis Stocks Regain Ground Last Week Ahead of Elections
ACCESSWIRE - Mon Oct 27, 9:00AM CDT
Whitefish, MT / ACCESSWIRE / October 27, 2014 / Cannabis stocks gained ground last week, led by a ~15% recovery in shares of GW Pharmaceuticals plc (NASDAQ: GWPH). MedBox Inc. (OTC: MDBX) shares also rose more than 25%, sending the overall Marijuana Index(TM) significantly higher for the week. Traders will be watching for a continuation of these trends into this week, although a lot may depend on the movements of the larger overall market.
GWPH: 105.64 (+0.79)

Cannabis Therapy Gears Up Canna-Pet Business
ACCESSWIRE - Thu Oct 23, 8:05AM CDT
WHITEFISH, MT / October 23, 2014 / The widespread legalization of medical cannabis may be helping mankind deal with many unmet medical needs, but man's best friend has been largely ignored.
PETS: 16.53 (+0.28), WOOF: 56.07 (+0.76), PETM: 82.98 (+0.03)

Cannabis Therapy Corp. Announces Revenue Milestone With Launch of Updated Canna-Pet(TM) Website
Marketwired - Wed Oct 22, 8:07AM CDT
Cannabis Therapy Corp. (OTCQB: CTCO) (the "Company", a development stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, ultra-low THC, cannabinoid-based medicinal therapies and supplements (Nutraceuticals), is extremely pleased to announce the launch of its all-new Canna-Pet(TM) commercial website (www.canna-pet.com).

Neutra Corp Doubles but Cannabis Stocks Move Largely Lower Last Week
ACCESSWIRE - Mon Oct 06, 8:06AM CDT
Whitefish, MT / Oct 6, 2014 / Cannabis industry stocks moved lower last week, according to the Marijuana Index(tm). Top gainers included Neutra Corp. (OTC: NTRR), which soared more than 100%, after its joint venture partner Vertigo Technologies acquired Contain a Grow. Industry bellwether GW Pharmaceuticals plc (NASDAQ: GWPH) also moved higher later in the week after it was upgraded by Zacks from Neutral to Outperform.
INSY: 36.20 (+0.23), GWPH: 105.64 (+0.79)

Cannabis Therapy's Hemp Harvest Paves Way to Commercialization
ACCESSWIRE - Tue Sep 30, 8:58AM CDT
WHITEFISH, MT / September 30, 2014 / Through an agreement with Rocky Mountain Hemp Inc., a relatively known micro-cap cannabis company will produce the first U.S.-grown hemp used in a commercial product in over 60 years. The low-THC and CBD-rich hemp will be used to support near-term commercial endeavors.
GWPH: 105.64 (+0.79)

Cannabis Therapy Corp. Harvests Its First Colorado Hemp Crop
Marketwire - Mon Sep 29, 8:02AM CDT
Cannabis Therapy Corp. (OTCQB: CTCO) (the "Company", a development stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, ultra-low THC, cannabinoid-based medicinal therapies and supplements (Nutraceuticals), is very pleased to announce it recently passed pre-harvest inspection by the Colorado Department of Agriculture, and subsequently harvested its first ever hemp crop which is now slated for near term product development and commercial applications.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Faces Accountability Trials in Business 2027

Updated Category News Views 31

Charting the AI Accountability Course In 2027, the corporate AI landscape won't be the Wild West anymore; it's morphing into a structured battlefield where the winners will be those who successfully enforce accountability. The hands-off, carte blanche days of AI are fading fast, and businesses are starting to scrutinize the AI tools they've been throwing money at. "The...

Continue Reading
KT&G Launches Heated Tobacco in Kazakhstan's Market

Updated Category News Views 99

KT&G Lights Up Kazakhstan In a bold move, KT&G is laying down the gauntlet in Kazakhstan's tobacco market, introducing its cutting-edge heated tobacco gizmo and a handful of sleek FAIIM sticks. Launching this October, these aren't just any devices—they're the FLEX locals have been waiting for, rebranded from South Korea's lil AIBLE and AIIM but made to fit right in with...

Continue Reading
Huawei's 2026 Leap in Gartner Magic Quadrant Recognition

Updated Category News Views 64

China's Telecom Giant Steps Up Globally Gartner's all about benchmarks and bragging rights in the tech world, and brother, Huawei just grabbed a major piece of that spotlight in 2026. They've snagged a spot in the coveted Leaders Quadrant of the Gartner Magic Quadrant for Infrastructure Platform Consumption Services. Now, why should folks with skin in the game care?...

Continue Reading
WSIB Slashes Registration Time with Guidewire Boost

Updated Category News Views 24

Quick Fix: Streamlining Ontario's Employer Registration Alright, let's cut through the formalities and tell it like it is: Ontario's Workplace Safety and Insurance Board (WSIB) isn't messing around anymore. They've yanked their antiquated paper-laden process into the digital age, slicing the employer registration wait down from an agonizing eight to ten-day ordeal to a...

Continue Reading
Goodyear's Strategic Shift: New Leadership, New Path

Updated Category News Views 15

Big Shoes, Bigger Expectations Who's steering the Goodyear ship now that Mark Stewart's out the door? Roger Wood's the name, interim CEO is the game. Don't fret too much—the board's hustling to nail down a permanent top dog. But this isn't a musical chairs game; it's a full-on strategic shift. Goodyear's forming committees, juggling ideas, and ripping through their...

Continue Reading
ASMAX Unleashes Next-Level Motorcycle Comms at EICMA

Updated Category News Views 141

Transforming the Motorcycle Communication Landscape Motorcycling ain't just about the roaring engines and the rubber on the road. In the world of helmets and handlebars, some bright minds are weaving tech magic at the EICMA 2026 in Milan. ASMAX has rolled out its shiny new RoamX intercom gadget, leaving folks buzzing at Hall 6. What RoamX Brings to the Table This ain't...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 592

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 322

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Bybit Expands On-Chain Access: Japanese Equity Focus

Updated Category News Views 43

Bybit's Bold Foray Into Japanese Equities Isn't every trader just itching to talk about Japan these days? Well, Bybit's got your back with its latest maneuvers. The platform is broadening its scope by diving headfirst into Japanese equities with a fresh offering—JPE backed by JX, no less. Bybit's RWA Earn platform isn't sticking to the boring fixed-income strategy...

Continue Reading
WIN Expands Global Family Support to 124 Countries

Updated Category News Views 13

WIN's Ambitious Global Expansion In the ever-twisting labyrinth of corporate benefits, WIN is stepping up its game. We're talking an expansion that balloons past traditional fertility offerings into a global medley of support services covering every conceivable family and health scenario. It ain’t just about making babies anymore. When you're dealing with 124 countries,...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Developments from Compass Therapeutics at Upcoming Meeting

Updated Category News Views 79

Upcoming Poster Presentation Announcement Compass Therapeutics, Inc. (NASDAQ: CMPX), a pioneering clinical-stage biopharmaceutical company specializing in oncology, has announced an exciting opportunity to showcase its research at the upcoming 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting. This event is scheduled to take place from November 8–10, 2024,...

Continue Reading
Good Times Restaurants Posts Positive Growth in Q1 2025

Updated Category News Views 186

Good Times Restaurants Reports Strong Financial Performance Good Times Restaurants Inc. (NASDAQ: GTIM), the well-known operator of popular dining brands like Bad Daddy's Burger Bar and Good Times Burgers & Frozen Custard, has released its financial results for the first quarter of the fiscal year. The company has shown robust growth, signaling a positive trend in its...

Continue Reading
Alaska Air Group Reveals Financial Outlook and Updates

Updated Category News Views 124

Alaska Air Group Provides Financial Update Today, Alaska Air Group, Inc. (NYSE: ALK), a leading American airline, revealed important information regarding its financial outlook through an official filing with the Securities and Exchange Commission (SEC). This update outlines the company’s present financial conditions and operations, providing key insights valuable to...

Continue Reading
Transforming Tool Tracking Software for Unmatched Efficiency

Updated Category News Views 184

Expanding Tool Tracking Software Market Dynamics The global tool tracking software industry is on an impressive trajectory, experiencing substantial growth. Currently valued at approximately US$ 39.02 billion, the market is expected to escalate to US$ 124.90 billion by 2033. This marks a notable compound annual growth rate (CAGR) of 13.8%, highlighting the increasing...

Continue Reading
Major Developments in Class Actions for Driven Brands and More

Updated Category News Views 200

Investigating Shareholder Claims for Driven Brands Holdings, Inc. As a long-term shareholder of Driven Brands Holdings, Inc. (NASDAQ: DRVN), you may be interested in the ongoing investigation by the Grabar Law Office. This investigation seeks answers on whether certain company officers have fulfilled their fiduciary responsibilities. If you have held your shares...

Continue Reading